Chembio Diagnostics
Last month, the US CDC called for timely syphilis testing and treatment after data showed almost 90 percent of newborn syphilis cases in 2022 may have been prevented.
ProciseDx Gets US Marketing Clearance for Infliximab, Adalimumab POC Monitoring Tests
The firm plans this year to launch in the US its tests used to measure drug levels in inflammatory bowel disease patients and guide treatment.
In Brief This Week: Chembio, Gradientech, PerkinElmer, Becton Dickinson, More
News items for the week of April 24, 2023.
In Brief This Week: SQI Diagnostics, Chembio, Accelerate, Seegene, Freenome, More
News items for the week of March 27, 2023.
Top Five Articles on 360Dx Last Week: FDA Regulation of LDTs; Visby FDA Clearance; and More
Last week, readers were most interested in a story about moves by the FDA to regulate LDTs, which could result in legal actions.